Xie Jinghui, Luo Dan, Xing Pengfei, Ding Weijun
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
J Inflamm Res. 2025 Mar 22;18:4251-4266. doi: 10.2147/JIR.S506964. eCollection 2025.
Ferroptosis, an iron-dependent programmed mechanism of cell death that is driven by lipid peroxidation, is an important pathogenic factor in oncological and non-oncological disorders. Dysregulation of iron and lipid metabolism profoundly influences disease progression through ferroptosis modulation. Signal transducer and activator of transcription 3 (STAT3), a transcriptional regulator, regulates ferroptosis by binding to promoters of key molecules such as solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), and ferritin heavy chain 1 (FTH1). In this review, we described the role of STAT3 in supporting tumors survival by suppressing ferroptosis in malignancies, and bidirectionally regulating ferroptosis in non-tumors to regulate the development of the disease. We also reported emerging therapeutic strategies that target STAT3-mediated ferroptosis, including natural phytochemicals, inhibitors, and nanotechnology-enabled drug delivery systems. These advancements deepen the mechanistic understanding of ferroptosis regulation, and provide new theoretical bases and strategies to treat ferroptosis-related diseases.
铁死亡是一种由脂质过氧化驱动的铁依赖性程序性细胞死亡机制,是肿瘤和非肿瘤疾病中的一个重要致病因素。铁和脂质代谢的失调通过调节铁死亡深刻影响疾病进展。信号转导和转录激活因子3(STAT3)作为一种转录调节因子,通过与溶质载体家族7成员11(SLC7A11)、谷胱甘肽过氧化物酶4(GPX4)和铁蛋白重链1(FTH1)等关键分子的启动子结合来调节铁死亡。在这篇综述中,我们描述了STAT3在恶性肿瘤中通过抑制铁死亡来支持肿瘤存活,以及在非肿瘤中双向调节铁死亡以调控疾病发展方面的作用。我们还报道了针对STAT3介导的铁死亡的新兴治疗策略,包括天然植物化学物质、抑制剂和纳米技术支持的药物递送系统。这些进展加深了对铁死亡调节机制的理解,并为治疗铁死亡相关疾病提供了新的理论基础和策略。